Corrigendum to:“Ameliorative delivery of docetaxel and curcumin using PEG decorated lipomers: A cutting-edge in-vitro/ in-vivo appraisal”(Journal of Drug Delivery Science and Technology, (2024), 97, C, (105814), (S1773224724004830), 10.1016/j.jddst.2024.105814)

  • Imran Tariq*
  • , Hira Hassan
  • , Sajid Ali
  • , Syed Atif Raza
  • , Pervaiz Akhtar Shah
  • , Muhammad Yasir Ali
  • , Zain Tariq
  • , Udo Bakowsky*
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The authors regret that incorrect histopathological images were accidently shown in Fig. 9: the panels representing the groups “Controlled group” and “Cur LPs” inadvertently contain repeated images. We removed the repeated images for the panels representing the groups “controlled group” and “Cur LPs” and included original images of all samples. We would like to correct these illustrations herewith. The authors would like to apologise for any inconvenience caused.(Figure

Original languageEnglish
Article number107665
JournalJournal of Drug Delivery Science and Technology
DOIs
StateAccepted/In press - 2025
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2025 Elsevier B.V.

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Corrigendum to:“Ameliorative delivery of docetaxel and curcumin using PEG decorated lipomers: A cutting-edge in-vitro/ in-vivo appraisal”(Journal of Drug Delivery Science and Technology, (2024), 97, C, (105814), (S1773224724004830), 10.1016/j.jddst.2024.105814)'. Together they form a unique fingerprint.

Cite this